These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8921370)

  • 41. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.
    Bunting KD; Lu T; Kelly PF; Sorrentino BP
    Hum Gene Ther; 2000 Nov; 11(17):2353-64. PubMed ID: 11096440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Txk: genomic organization, structure and contiguous physical linkage with the Tec gene.
    Ohta Y; Haire RN; Amemiya CT; Litman RT; Träger T; Riess O; Litman GW
    Oncogene; 1996 Feb; 12(4):937-42. PubMed ID: 8632917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural organization of the human selenium-dependent phospholipid hydroperoxide glutathione peroxidase gene (GPX4): chromosomal localization to 19p13.3.
    Kelner MJ; Montoya MA
    Biochem Biophys Res Commun; 1998 Aug; 249(1):53-5. PubMed ID: 9705830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency.
    Liongue C; Ratnayake T; Basheer F; Ward AC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is JAK3 a new drug target for immunomodulation-based therapies?
    Papageorgiou AC; Wikman LE
    Trends Pharmacol Sci; 2004 Nov; 25(11):558-62. PubMed ID: 15491777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and molecular characterization of a novel member of the siglec family (SIGLEC9).
    Foussias G; Yousef GM; Diamandis EP
    Genomics; 2000 Jul; 67(2):171-8. PubMed ID: 10903842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The human fatty acid transport protein-1 (SLC27A1; FATP-1) cDNA and gene: organization, chromosomal localization, and expression.
    Martin G; Nemoto M; Gelman L; Geffroy S; Najib J; Fruchart JC; Roevens P; de Martinville B; Deeb S; Auwerx J
    Genomics; 2000 Jun; 66(3):296-304. PubMed ID: 10873384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).
    Macchi P; Villa A; Giliani S; Sacco MG; Frattini A; Porta F; Ugazio AG; Johnston JA; Candotti F; O'Shea JJ
    Nature; 1995 Sep; 377(6544):65-8. PubMed ID: 7659163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal diagnosis of JAK3 deficient SCID.
    Schumacher RF; Mella P; Lalatta F; Fiorini M; Giliani S; Villa A; Candotti F; Notarangelo LD
    Prenat Diagn; 1999 Jul; 19(7):653-6. PubMed ID: 10419614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Janus kinase-3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation.
    Säemann MD; Zeyda M; Stulnig TM; Böhmig GA; Wekerle T; Hörl WH; Zlabinger GJ
    Transpl Int; 2004 Oct; 17(9):481-9. PubMed ID: 15368094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel mutation in the JH4 domain of JAK3 causing severe combined immunodeficiency complicated by vertebral osteomyelitis.
    Qamar F; Junejo S; Qureshi S; Seleman M; Bainter W; Massaad M; Chou J; Geha RS
    Clin Immunol; 2017 Oct; 183():198-200. PubMed ID: 28917720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel JAK3 mutation in a Japanese patient with severe combined immunodeficiency.
    Uchiyama T; Kumaki S; Fujiwara M; Nishida Y; Hakozaki I; Imai K; Du W; Yoshinari M; Sasahara Y; Tsuchiya S
    Pediatr Int; 2005 Oct; 47(5):575-8. PubMed ID: 16190968
    [No Abstract]   [Full Text] [Related]  

  • 54. Zebrafish Model of Severe Combined Immunodeficiency (SCID) Due to JAK3 Mutation.
    Basheer F; Lee E; Liongue C; Ward AC
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene.
    Rosnet O; Matteï MG; Marchetto S; Birnbaum D
    Genomics; 1991 Feb; 9(2):380-5. PubMed ID: 2004790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving transplantation for IL2RG/JAK3 SCID.
    Keller MD
    Blood; 2017 Apr; 129(15):2049-2050. PubMed ID: 28408423
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term survival in severe combined immune deficiency: the role of persistent maternal engraftment.
    Tezcan I; Ersoy F; Sanal O; Turul T; Uckan D; Balci S; Hicsonmez G; Prieur M; Caillat-Zucmann S; Le Deist F; De Saint Basile G
    J Pediatr; 2005 Jan; 146(1):137-40. PubMed ID: 15644840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunology: JAK3 inhibition—is it sufficient?
    Leonard WJ; Mitra S; Lin JX
    Nat Chem Biol; 2016 May; 12(5):308-10. PubMed ID: 27556128
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibiting interferon pathways in dermatomyositis: rationale and preliminary evidence.
    Casal-Dominguez M; Pinal-Fernandez I; Mammen AL
    Curr Treatm Opt Rheumatol; 2021 Sep; 7(3):258-271. PubMed ID: 37456764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case Report: Mutations in
    Pan Y; Pan H; Lian C; Wu B; Lin J; Huang G; Cui B
    Front Immunol; 2022; 13():1055607. PubMed ID: 36466884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.